Funder: American Heart Association
Due Dates: January 19, 2026 (Letter of Intent, 3:00 pm CT) | March 23, 2026 (Full proposal, 3:00 pm CT)
Funding Amounts: Up to $300,000 total per award (including 10% indirect costs) over 2 years; up to 5 awards; optional AWS credits up to $30,000 for data analysis.
Summary: Supports research on the effects of GLP-1/GIP agonists in individuals with cardiovascular, kidney, and metabolic disease or obesity, using advanced data-driven approaches.
Key Information: Letter of Intent is required; only invited applicants may submit a full proposal.